article thumbnail

Calpain inhibition takes center stage against atrial fibrillation in the diabetic heart

HeartRhythm

Diabetes mellitus (DM) is a public health problem that continues to grow worldwide. In the United States the Center for Disease Control and Prevention estimates that it affects 11.6% of the population.1

article thumbnail

Frail hypertensive older adults with prediabetes and chronic kidney disease: insights on organ damage and cognitive performance - preliminary results from the CARYATID study

Cardiovascular Diabetology

Hypertension and chronic kidney disease (CKD) pose significant public health challenges, sharing intertwined pathophysiological mechanisms. Prediabetes is recognized as a precursor to diabetes and is often acc.

article thumbnail

Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050—Prevalence of Risk Factors and Disease: A Presidential Advisory From the American Heart Association

Circulation

Diabetes (16.3% Clinical and public health interventions are needed to effectively manage, stem, and even reverse these adverse trends. in 2020 to 61.0% to 26.8%) and obesity (43.1% to 60.6%) will increase, whereas hypercholesterolemia will decline (45.8%

article thumbnail

Why Insulin Resistance Is The Biggest Silent Risk Factor For Heart Disease.

Dr. Paddy Barrett

Everyone sits somewhere on the scale of insulin sensitivity from very insulin sensitive to very insulin resistant at the point of type 2 diabetes. When insulin resistance progresses to type 2 diabetes, that risk increases to a 10-fold increase in risk. BMC Public Health 24 , 574 (2024). Measuring Insulin Resistance.

article thumbnail

Proposed Risk Factor Tool Finds Heart Failure Rates are Higher Among American Indian Adults

DAIC

The analysis also found smoking, Type 2 diabetes status, kidney damage, previous heart attack and high blood pressure are major modifiable determinants of developing heart failure over five to 10 years among American Indian adults. and a researcher at Columbia University’s Mailman School of Public Health in New York City.

article thumbnail

Chelation Therapy Does Not Improve Outcomes after Heart Attack

DAIC

and Canadian patients with diabetes and a history of heart attack,” said Gervasio A. The original TACT trial, which ran from 2003 to 2012, suggested modest benefits from edetate disodiumbased infusions in reducing cardiovascular events after a heart attack over a median follow-up of 55 months, especially in people with diabetes.

article thumbnail

National A-Fib Numbers Higher Than Previously Tought

DAIC

A-Fib, as the condition is commonly known, has been on the rise for at least the past decade, driven by the aging of the population, along with increasing rates of hypertension, diabetes and obesity. Earlier projections had estimated that 3.3 million U.S. The study appears Sept. 11 in the Journal of the American College of Cardiology JACC.